Tilray Medical, a subsidiary of Tilray Brands, has recently introduced Redecan-branded medical cannabis products in the Australian market. The subsidiary is making available two EU-GMP-certified products under the renowned Canadian brand to patients in Australia.
For more information on this development, please refer to the link provided.
In addition to this announcement, here are some of the top cannabis news stories for the week:
1. High Tide reports record revenue of $131.7 million in its Q3 2024 financial results.
2. Aurora Cannabis is advancing auto-flowering research, unveiling key insights for future cultivation.
3. Lifeist has concluded a CannMart transaction with Simply Solventless Concentrates.
Furthermore, here are the top cannabis stocks from September 3 to September 19, 2024:
1. T.TLRY (Tilray Brands Inc.) with 9,175 views.
2. T.WEED (Canopy Growth Corp.) with 4,778 views.
3. C.CURA (Curaleaf Holdings Inc.) with 3,713 views.
4. T.LABS (Medipharm Labs Corp.) with 2,227 views.
5. C.OILS (Nextleaf Solutions Ltd.) with 1,221 views.
6. T.OGI (OrganiGram Holdings Inc.) with 717 views.
Please note that the information provided in this article is for informational purposes only and should not be construed as investment advice. For full disclaimer information, please visit the link provided.
